Mexico Metagenomics Market Size & Outlook, 2023-2030
Mexico metagenomics market, 2018-2030 (US$M)
Related Markets
Mexico metagenomics market highlights
- The Mexico metagenomics market generated a revenue of USD 41.0 million in 2023 and is expected to reach USD 101.5 million by 2030.
- The Mexico market is expected to grow at a CAGR of 13.8% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
Metagenomics market data book summary
| Market revenue in 2023 | USD 41.0 million |
| Market revenue in 2030 | USD 101.5 million |
| Growth rate | 13.8% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, Mexico accounted for 2.0% of the global metagenomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil metagenomics market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 191.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico metagenomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to metagenomics market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 61.46% in 2023. Horizon Databook has segmented the Mexico metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
High incidence of chronic & infectious diseases and growing medical tourism in the country, due to its cost-effective healthcare services, are significantly boosting the demand for metagenomics tools for clinical applications. Furthermore, Mexico is the second-largest pharmaceutical market in Latin America after Brazil. It has emerged as one of the potential countries for biopharmaceutical products, owing to the presence of skilled scientists, low manufacturing costs, and advanced legal framework.
Moreover, high penetration of U.S.-based biotechnology companies in Mexico has supported the country’s biotechnology sector. In addition, the Mexican government has prioritized growth and innovation in the biotechnology sector. Thus, growth in Mexico’s biopharmaceutical and biotechnology industries is anticipated to create high demand for NGS tools in the region and support market growth. However, low affordability of technologically advanced systems in the country may hamper market growth during the forecast period.
Reasons to subscribe to Mexico metagenomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico metagenomics market databook
-
Our clientele includes a mix of metagenomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico metagenomics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico metagenomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico metagenomics market size, by product, 2018-2030 (US$M)
Mexico Metagenomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
